CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Operating Activities:
Net loss	$ (475,690)	$ (897,467)
Reconciliation of net loss to net cash provided by (used in) operating activities:
Depreciation and amortization	21,832	8,989
Non-cash stock-based compensation	102,525	151,457
Provision for excess and obsolete inventory	358,075	0
Right-of-use assets expensed, net of credits received	40,187	17,117
Other items, net	(25,059)	2,739
Changes in operating assets and liabilities:
Inventory	(426,466)	0
Accounts receivable, prepaid expenses, and other assets	171,325	209,221
Accounts payable, accrued expenses, and other liabilities	90,418	180,708
Deferred revenue	(155,268)	992,590
Net cash provided by (used in) operating activities	(298,121)	665,354
Investing Activities:
Purchases of property and equipment	(66,033)	(41,122)
Internal-use software development costs	(4,888)	0
Purchases of marketable securities	0	(2,167)
Proceeds from maturities and sale of marketable securities	0	159,807
Net cash provided by (used in) investing activities	(70,921)	116,518
Financing Activities:
Net proceeds from sales of common stock	179,385	564,859
Net proceeds from the exercise of stock-based awards	67	21,441
Finance lease payments	(45,904)	(63,876)
Net cash provided by financing activities	133,548	522,424
Effect of exchange rate on cash, cash equivalents, and restricted cash	257	(6,208)
Net increase (decrease) in cash, cash equivalents, and restricted cash	(235,237)	1,298,088
Cash, cash equivalents, and restricted cash at beginning of period	1,528,259	648,738
Cash, cash equivalents, and restricted cash at end of period	1,293,022	1,946,826
Supplemental disclosure of non-cash activities:
Right-of-use assets from new lease agreements	118,262	34,914
Capital expenditures included in accounts payable and accrued expenses	11,984	7,884
Supplemental disclosure of cash flow information:
Cash interest payments	17,260	17,768
Cash paid for income taxes	$ 17,843	$ 6,041